Potentiated Skin Permeation and Antitumor Efficacy of Fulvestrant-Loaded High-Permeation Vesicles for Localized Breast Cancer Treatment
ACS Biomaterials Science & Engineering · 09.11.2026 · 12 (11) · 6226-6244
DOI: 10.1021/acsbiomaterials.6c01112 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 20.10.2026. Verfasst von Junia Akhtar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67…. Hauptthemen laut MEDLINE: Breast Neoplasms, Skin Absorption, Fulvestrant, Skin. Die Arbeit nennt 60 Literaturangaben.
Abstract (Originalsprache)
Fulvestrant (FLV) is a selective estrogen receptor degrader used for hormone receptor-positive breast cancer. Nevertheless, its delivery is limited by low aqueous solubility and repeated intramuscular administration. Considering these drawbacks, a high-permeation vesicle-in-gel system (HPV-gel) was explored as a localized transdermal approach for FLV and evaluated for its physicochemical, permeation, cellular, pharmacokinetic, antitumor, and safety performance. Accordingly, FLV/HPVs were prepared using soya phosphatidylcholine and a ternary permeation-enhancer combination of sodium oleate (SO), diethylene glycol monoethyl ether (DEGEE), and propylene glycol (PG). Enhancer proportions were optimized using a D-optimal mixture design based on vesicle size, PDI, and entrapment efficiency. The optimized composition contained 80% phospholipid and 20% of a permeation enhancer mixture, comprising SO, DEGEE, and PG in a ratio of 6:1.5:2.5. FLV/HPVs showed a particle size of 94.02 ± 1.10 nm, a PDI of 0.241 ± 0.029, a zeta potential of –38.6 ± 1.2 mV, an entrapment efficiency of 85.79 ± 3.72%, a practical drug loading of 8.58 ± 0.16%, and a deformability index of 1.62 ± 0.08. The optimized vesicles were incorporated into a 1.5% w/v Carbopol 934P gel and compared with FLV-gel and FLV/Lipo-gel with the same gel base and an equivalent FLV amount. FLV/HPVs-gel showed sustained drug release and increased FLV permeation by nearly 8-fold and 3-fold compared with FLV-gel and FLV/Lipo-gel, respectively, with higher intradermal retention and deeper dermal distribution. Following topical administration, FLV/HPVs-gel increased Cmax by ∼8.3- and ∼2-fold and AUC0-168 h by ∼8.1- and ∼2.6-fold compared with FLV-gel and FLV/Lipo-gel, respectively, while showing plasma concentration–time profile closer to FLV (i.m.). In 4T1 tumor-bearing mice, FLV/HPVs-gel showed the strongest tumor-suppressive effect, accompanied by greater intratumoral penetration, while biochemical parameters, major organ histology, TEWL, and skin histology indicated acceptable systemic and local safety. Overall, FLV/HPVs-gel improved skin permeation, drug exposure, and antitumor activity, suggesting its potential as a noninvasive transdermal approach for FLV in breast cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali, Punjab160062, India.
ORCID-Profile: Junia Akhtar, Brojendra Nath Saren, Smriti Bhardwaj, Sanyog Jain
Zitieren
APA
Akhtar, J., Saren, B. N., Yadav, V., Bhardwaj, S., & Jain, S. (2026). Potentiated Skin Permeation and Antitumor Efficacy of Fulvestrant-Loaded High-Permeation Vesicles for Localized Breast Cancer Treatment. ACS Biomaterials Science & Engineering, 12(11), 6226-6244. https://doi.org/10.1021/acsbiomaterials.6c01112
Vancouver
Akhtar J, Saren BN, Yadav V, Bhardwaj S, Jain S. Potentiated Skin Permeation and Antitumor Efficacy of Fulvestrant-Loaded High-Permeation Vesicles for Localized Breast Cancer Treatment. ACS Biomaterials Science & Engineering. 2026;12(11):6226-6244. doi:10.1021/acsbiomaterials.6c01112
BibTeX
@article{Akhtar2026,
author = {Akhtar, Junia and Saren, Brojendra Nath and Yadav, Vivek and Bhardwaj, Smriti and Jain, Sanyog},
title = {Potentiated Skin Permeation and Antitumor Efficacy of Fulvestrant-Loaded High-Permeation Vesicles for Localized Breast Cancer Treatment},
journal = {ACS Biomaterials Science & Engineering},
year = {2026},
volume = {12},
number = {11},
pages = {6226--6244},
doi = {10.1021/acsbiomaterials.6c01112}
}
EUVIMED